Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan.

导出 OA

翻译打印收藏纠错

作者： Tehmina Nafees Sonia,Khan ^[1] ; Samina Naz,Mukry ^[2] ; Shahtaj,Masood ^[3] ; Lubna,Meraj ^[4] ; Bikha Ram,Devrajani ^[5] ; Javed,Akram ^[6] ; Naveena,Fatima ^[2] ; Sidra,Maqsood ^[2] ; Ayesha,Mahesar ^[7] ; Roomana,Siddiqui ^[8] ; Sadia,Ishaque ^[9] ; Muhammad Bilal,Afzal ^[10] ; Sanam,Mukhtar ^[11] ; Sara,Ahmed ^[12] ; Arshi,Naz ^[13] ; Tahir Sultan,Shamsi ^[2]

作者单位： National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan. dr_tehmina@yahoo.com. ^[1] National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan. ^[2] Hayatabad Medical Complex, Peshawar, Pakistan. ^[3] Rawalpindi Medical University, Rawalpindi, Pakistan. ^[4] Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan. ^[5] University of Health Sciences, Lahore, Pakistan. ^[6] The Indus Hospital, Karachi, Pakistan. ^[7] Regional Blood Center, Sukkur, Pakistan. ^[8] Orthopedic and Medical Institute (OMI) Hospital, Karachi, Pakistan. ^[9] Liaquat National Hospital, Karachi, Pakistan. ^[10] Shah Medical Center, Karachi, Pakistan. ^[11] Saifee Hospital, Karachi, Pakistan. ^[12] Patel Hospital, Karachi, Pakistan. ^[13]

关键词 COVID-19 Convalescent CP recipient Convalescent plasma (CP)SARS CoV2 infection SOFA score